IRIS
POGGIO, FRANCESCA BENEDETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.805
AS - Asia 667
NA - Nord America 363
SA - Sud America 70
AF - Africa 13
Totale 5.918
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 4.662
US - Stati Uniti d'America 344
SG - Singapore 276
CN - Cina 180
VN - Vietnam 134
FR - Francia 41
BR - Brasile 35
FI - Finlandia 35
HK - Hong Kong 32
DE - Germania 28
AR - Argentina 12
GB - Regno Unito 11
JP - Giappone 11
MX - Messico 9
EC - Ecuador 7
PY - Paraguay 6
CA - Canada 5
IN - India 5
NL - Olanda 5
DZ - Algeria 4
ID - Indonesia 4
RU - Federazione Russa 4
VE - Venezuela 4
IQ - Iraq 3
KE - Kenya 3
AT - Austria 2
BE - Belgio 2
CH - Svizzera 2
CO - Colombia 2
ES - Italia 2
IE - Irlanda 2
JO - Giordania 2
NP - Nepal 2
PE - Perù 2
PH - Filippine 2
RO - Romania 2
SE - Svezia 2
TR - Turchia 2
TW - Taiwan 2
UA - Ucraina 2
ZA - Sudafrica 2
AZ - Azerbaigian 1
BD - Bangladesh 1
BO - Bolivia 1
BS - Bahamas 1
CI - Costa d'Avorio 1
CL - Cile 1
CR - Costa Rica 1
CU - Cuba 1
DO - Repubblica Dominicana 1
EG - Egitto 1
IL - Israele 1
KR - Corea 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
MR - Mauritania 1
MT - Malta 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PK - Pakistan 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 5.918
Salva come PNG Salva come JPEG
Città #
Genoa 1.939
Genova 1.853
Rapallo 404
Vado Ligure 388
Singapore 136
San Jose 107
Ho Chi Minh City 44
Council Bluffs 43
Ashburn 40
Beijing 37
Lauterbourg 35
Helsinki 31
Hanoi 30
Hong Kong 29
Bordighera 22
New York 22
Santa Clara 22
Frankfurt am Main 18
Tokyo 9
Orem 8
São Paulo 8
Agawam 7
Haiphong 7
Rome 7
Los Angeles 6
Mexico City 6
Milan 6
Shenzhen 6
Schiffdorf 5
City of London 4
Da Nang 4
Hải Dương 4
Lappeenranta 4
Ninh Bình 4
Tianjin 4
Asunción 3
Atlanta 3
Brasília 3
Buffalo 3
Chicago 3
Curitiba 3
Gallarate 3
Paris 3
Phủ Lý 3
Quito 3
Toronto 3
Amsterdam 2
Biên Hòa 2
Brescia 2
Brussels 2
Córdoba 2
Dublin 2
Guayaquil 2
Gurugram 2
London 2
Nasiriyah 2
Nuremberg 2
Phoenix 2
San Justo 2
Seattle 2
Stockholm 2
Thái Nguyên 2
Verona 2
Vĩnh Long 2
Vũng Tàu 2
Zurich 2
Abidjan 1
Acolman 1
Ahmedabad 1
Algiers 1
Almaty 1
Almirante Tamandaré 1
Amman 1
Arafat 1
Araguaiana 1
As Sālimīyah 1
Baku 1
Bandar Lampung 1
Bismarck 1
Boca Toma 1
Boston 1
Bowling Green 1
Bremen 1
Bucharest 1
Buenos Aires 1
Buk-gu 1
Bình Dương 1
Bình Phước 1
Bắc Giang 1
Camaçari 1
Camden 1
Can Tho 1
Caracas 1
Caruaru 1
Chalco 1
Chengdu 1
Chennai 1
Ciudad del Este 1
Cochabamba 1
Columbus 1
Totale 5.406
Salva come PNG Salva come JPEG
Nome #
Mortality in adult patients with solid or hematological malignancies and SARS-CoV-2 infection with a specific focus on lung and breast malignancies: a systematic review and meta-analysis 220
Italian survey on managing immune checkpoint inhibitors in oncology during COVID-19 outbreak 202
Prospective study to optimize care and improve knowledge on ovarian function and/or fertility preservation in young breast cancer patients: Results of the pilot phase of the PREgnancy and FERtility (PREFER) study 194
Management of young women with early breast cancer 186
Analysis of in vitro ADCC and clinical response to trastuzumab: possible relevance of Fc gamma RIIIA/Fc gamma RIIA gene polymorphisms and HER-2 expression levels on breast cancer cell lines 176
Hormonal therapy followed by chemotherapy or the reverse sequence as first-line treatment of hormone-responsive, human epidermal growth factor receptor-2 negative metastatic breast cancer patients: Results of an observational study 172
Concurrent versus sequential adjuvant chemo-endocrine therapy in hormone-receptor positive early stage breast cancer patients: a systematic review and meta-analysis 168
Gonadotropin-releasing hormone agonists during chemotherapy for preservation of ovarian function and fertility in premenopausal patients with early breast cancer: A systematic review and meta-analysis of individual patient–level data 168
New insights on the role of luteinizing hormone releasing hormone agonists in premenopausal early breast cancer patients 162
Single-agent PARP inhibitors for the treatment of patients with BRCA-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysis 160
News on the medical treatment of young women with early-stage HER2-negative breast cancer 159
T-DM1 Efficacy in Patients With HER2-positive Metastatic Breast Cancer Progressing After a Taxane Plus Pertuzumab and Trastuzumab: An Italian Multicenter Observational Study 159
Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: Systematic review and meta-analysis of randomized trials 158
Pegfilgrastim administration after 24 or 72 or 96 h to allow dose-dense anthracycline- and taxane-based chemotherapy in breast cancer patients: a single-center experience within the GIM2 randomized phase III trial 155
The BCY3/BCC 2017 survey on physicians' knowledge, attitudes and practice towards fertility and pregnancy-related issues in young breast cancer patients 153
Dose-dense adjuvant chemotherapy in early breast cancer patients: 15-year results of the Phase 3 Mammella InterGruppo (MIG)-1 study 152
Erratum to: Analysis of in vitro ADCC and clinical response to trastuzumab: possible relevance of FcγRIIIA/FcγRIIA gene polymorphisms and HER-2 expression levels on breast cancer cell lines 151
Patterns of care and clinical outcomes of first-line trastuzumab-based therapy in HER2-positive metastatic breast cancer patients relapsing after (Neo)adjuvant trastuzumab: An Italian multicenter retrospective cohort study 147
The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients 145
Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review 145
Platinum-based neoadjuvant chemotherapy in triple-negative breast cancer: a systematic review and meta-analysis 143
Role of fulvestrant in the treatment of postmenopausal metastatic breast cancer patients 139
Patterns of care at the end of life: a retrospective study of Italian patients with advanced breast cancer 134
Effect of dose-dense adjuvant chemotherapy in hormone receptor positive/HER2-negative early breast cancer patients according to immunohistochemically defined luminal subtype: an exploratory analysis of the GIM2 trial 134
Ovarian Suppression With Triptorelin During Adjuvant Breast Cancer Chemotherapy and Long-term Ovarian Function, Pregnancies, and Disease-Free Survival A Randomized Clinical Trial 133
Combination therapies for the treatment of HER2-positive breast cancer: current and future prospects 133
Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: exploratory analysis of the GIM2 trial 129
Controversies in Oncology: Surgery of the primary tumour in patients presenting with de novo metastatic breast cancer: to do or not to do? 127
Anthracycline, taxane, and trastuzumab-based neoadjuvant chemotherapy in HER2-positive early breast cancer: phase II trial 120
Role of dose-dense chemotherapy in high-risk early breast cancer 119
The landscape of combining immune checkpoint inhibitors with novel Therapies: Secret alliances against breast cancer 113
Factors associated with first-to-second-line attrition among patients with metastatic breast cancer in the real world 100
Protecting Ovaries During Chemotherapy Through Gonad Suppression: A Systematic Review and Meta-analysis 98
Fertility counseling of young breast cancer patients 96
"Positioning of tucatinib in the new clinical scenario of HER2-positive metastatic breast cancer: An Italian and Spanish consensus paper" 95
Practices and views about palliative care at the end of life: A survey of oncologists from the Italian region of Liguria 87
SNPs of aromatase predict long-term survival and aromatase inhibitor toxicity in patients with early breast cancer: a biomarker analysis of the GIM4 and GIM5 trials 85
Choosing the appropriate pharmacotherapy for breast cancer during pregnancy: what needs to be considered? 85
Efficacy of adjuvant chemotherapy schedules for breast cancer according to body mass index: results from the phase III GIM2 trial 81
Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial 78
Prognostic and clinical impact of the endocrine resistance/sensitivity classification according to international consensus guidelines for advanced breast cancer: an individual patient-level analysis from the Mammella InterGruppo (MIG) and Gruppo Italiano Mammella (GIM) studies 78
Corrigendum to ‘Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab: a multicenter, phase II, single arm trial (GIM11-BERGI)’: (ESMO Open (2021) 6(2), (S2059702921000089), (10.1016/j.esmoop.2021.100054)) 74
Adjuvant endocrine therapy choices in premenopausal patients with hormone receptor-positive early breast cancer: Insights from the prospective GIM23-POSTER study 74
Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab: a multicenter, phase II, single arm trial (GIM11-BERGI) 70
Extended therapy with letrozole as adjuvant treatment of postmenopausal patients with early-stage breast cancer: a multicentre, open-label, randomised, phase 3 trial 70
Insights on the association of anthropometric and metabolic variables with tumor features and genomic risk in luminal early breast cancer: Results of a multicentric prospective study 68
Different activity and toxicity of immunotherapy in monozygotic twins diagnosed with early triple-negative breast cancer: a case report 63
null 27
Comparison of suboptimal versus adequate ovarian function suppression in premenopausal women with early breast cancer treated with adjuvant endocrine therapy: An exploratory analysis of two prospective studies 21
Totale 6.106
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.840
article - articoli 19.840
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.680
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202197 0 0 0 0 0 0 0 0 0 45 19 33
2021/2022403 15 16 26 50 14 43 10 86 42 39 12 50
2022/2023478 46 51 6 54 71 73 10 38 68 2 57 2
2023/2024287 11 29 4 49 23 21 23 20 15 18 23 51
2024/20251.236 45 74 27 57 134 138 123 250 77 68 125 118
2025/20262.124 255 112 305 197 291 137 326 121 168 212 0 0
Totale 6.106